5 days ago
PACB
AnalystsMatthew SykesMatthew Sykes's Stock Forecasts
AnalystsMatthew Sykes
Analyst Ranking
Bottom 9%
#4157 out of 4560 analysts
Average Return
-2.32%
Win Rate
44%44 out of 99
Risk vs Reward
Poor
Good
Matthew Sykes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +123.36% | $40.76 | $91.04 | 2023-10-19 - 2024-04-23 | Strong Buy |
Natera IncNTRA | +94.57% | $46.79 | $91.04 | 2023-07-23 - 2024-04-23 | Strong Buy |
Invitae CorpNVTAQ | +93.99% | $1.48 | $0.09 | 2023-05-10 - 2024-02-05 | Strong Sell |
Invitae CorpNVTAQ | +93.41% | $1.35 | $0.09 | 2023-07-20 - 2024-02-05 | Strong Sell |
Invitae CorpNVTAQ | +92.99% | $1.27 | $0.09 | 2023-07-23 - 2024-02-05 | Strong Sell |
Matthew Sykes Analyst Color
Get additional color on Matthew Sykes's coverage of popular stocks
6 days ago
PACB
a year ago
DNA
Matthew Sykes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pacific Biosciences Of California IncPACB | 3 | Hold | $2.50 | +70.07% | Maintains | 5 days ago |
Veracyte IncVCYT | 3 | Strong Buy | $28.00 | +41.20% | Maintains | 9 days ago |
Natera IncNTRA | 10 | Strong Buy | $100.00 | +9.84% | Maintains | 9 days ago |
Guardant Health IncGH | 9 | Strong Buy | $28.00 | +61.48% | Maintains | 9 days ago |
Genedx Holdings CorpWGS | 8 | Hold | $11.00 | -8.33% | Maintains | 9 days ago |
Thermo Fisher Scientific IncTMO | 3 | Strong Buy | $640.00 | +11.38% | Maintains | 14 days ago |
Bruker CorpBRKR | 2 | Strong Sell | $74.00 | -10.26% | Maintains | 14 days ago |
Cytek Biosciences IncCTKB | 5 | Strong Buy | $10.00 | +72.12% | Maintains | 2 months ago |
Neogenomics IncNEO | 5 | Strong Buy | $19.00 | +34.18% | Maintains | 2 months ago |
Myriad Genetics IncMYGN | 8 | Strong Buy | $31.00 | +66.67% | Maintains | 3 months ago |
Singular Genomics Systems IncOMIC | 7 | Hold | $0.85 | +105.31% | Maintains | 3 months ago |
Ginkgo Bioworks Holdings IncDNA | 5 | Strong Sell | $1.10 | +26.29% | Maintains | 3 months ago |
Twist Bioscience CorpTWST | 7 | Strong Buy | $45.00 | +42.86% | Maintains | 3 months ago |
Avantor IncAVTR | 3 | Strong Buy | $26.00 | +1.36% | Maintains | 5 months ago |
Agilent Technologies IncA | 4 | Strong Buy | $145.00 | +4.17% | Maintains | 5 months ago |
Mettler Toledo International IncMTD | 4 | Hold | $1,030.00 | -17.02% | Maintains | 5 months ago |
Cue Health IncHLTH | 6 | Hold | $0.50 | +233.33% | Maintains | 5 months ago |
Maravai Lifesciences Holdings IncMRVI | 6 | Hold | $7.00 | -9.33% | Maintains | 5 months ago |
Exact Sciences CorpEXAS | 4 | Strong Buy | $90.00 | +41.67% | Maintains | 6 months ago |
Revvity IncRVTY | 2 | Strong Buy | $105.00 | +1.45% | Maintains | 6 months ago |
Danaher CorpDHR | 2 | Strong Buy | $215.00 | -15.06% | Maintains | 6 months ago |
Invitae CorpNVTAQ | 7 | Strong Sell | $0.50 | +461.80% | Maintains | 6 months ago |
Quanterix CorpQTRX | 10 | Strong Buy | $34.00 | +111.18% | Maintains | 7 months ago |
10x Genomics IncTXG | 3 | Strong Sell | $30.00 | +8.77% | Maintains | 9 months ago |
Lumiradx LtdLMDXF | 2 | Hold | $0.75 | +4,587.50% | Maintains | a year ago |
Caredx IncCDNA | 5 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Olink Holding Ab OLK | 4 | Hold | $18.00 | N/A | Maintains | a year ago |
Nautilus Biotechnology IncNAUT | 3 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Zymergen IncZY | 2 | Hold | $12.00 | N/A | Downgrades | 3 years ago |
Quotient LtdQTNTQ | 1 | Hold | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Qiagen NvQGEN | 3 | Hold | $53.56 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.